SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001170316-24-000002
Filing Date
2024-01-16
Accepted
2024-01-16 11:45:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4804
  Complete submission text file 0001170316-24-000002.txt   6224
Mailing Address PO BOX 1395 YARMOUTH ME 04096
Business Address
SINGER JAMES R (Filed by) CIK: 0001170316 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Subject) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92605 | Film No.: 24534251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)